Jennifer Rosenthal
Corporate Officer/Principal bij VIRALYTICS LTD.
Actieve functies van Jennifer Rosenthal
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VIRALYTICS LTD. | Corporate Officer/Principal | - | - |
CLARITY PHARMACEUTICALS LTD | Algemeen Adviseur | 01-10-2019 | - |
Loopbaan van Jennifer Rosenthal
Eerdere bekende functies van Jennifer Rosenthal
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
THE SUSTAINABLE NUTRITION GROUP LTD | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 | - |
Opleiding van Jennifer Rosenthal
Monash University | Doctorate Degree |
Statistieken
Internationaal
Australië | 5 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 3 |
Process Industries | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CLARITY PHARMACEUTICALS LTD | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
The Sustainable Nutrition Group Pty Ltd.
The Sustainable Nutrition Group Pty Ltd. Agricultural Commodities/MillingProcess Industries The Sustainable Nutrition Group Ltd. produces, manufactures, and distributes a range of hemp products in Australia. It is involved in hemp seed selection, farming, processing, and packaging, as well as distribution and sale of bulk and retail products. The company's products include hand sanitizers, hemp oils, hemp seeds, hemp protein powders, and hemp flour under the APH and Mt Elephant brands to retail, wholesale, and white label customers. The company was founded by James Hood and Tracie Rams dale in 1995 and is headquartered in Newtown, Australia. | Process Industries |
Viralytics Pty Ltd.
Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
- Beurs
- Insiders
- Jennifer Rosenthal
- Ervaring